Endometrial Origins of Stillbirth (EOS), a case–control study of menstrual fluid to understand and prevent preterm stillbirth and associated adverse pregnancy outcomes: study protocol

Kirstin Tindal, Caitlin E Filby, Caroline E Gargett, Fiona Cousins, Fiona L. Cousins, Kirsten Rebecca Palmer, Beverley Vollenhoven, Miranda Davies‐Tuck
BMJ open · 2023 · vol. 13(7) , pp. e068919 · doi:10.1136/bmjopen-2022-068919 · W4383874112
article OA: gold CC0 ⤵ 1 in-corpus citation
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This case-control study collected menstrual fluid to identify differences in women who experienced preterm stillbirth versus healthy births to understand endometrial origins of adverse pregnancy outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Introduction Current research aimed at understanding and preventing stillbirth focuses almost exclusively on the role of the placenta. The underlying origins of poor placental function leading to stillbirth, however, remain poorly understood. There is evidence demonstrating that the endometrial environment in which the embryo implants impacts not only the establishment of pregnancy but also the development of some pregnancy outcomes. Menstrual fluid has recently been applied to the study of menstrual disorders such as heavy menstrual bleeding or endometriosis, however, it has great potential in the study of adverse pregnancy outcomes. This study aims to identify differences in menstrual fluid and menstrual cycle characteristics of women who have experienced preterm stillbirth and other associated adverse pregnancy outcomes, compared with those who have not. The association between menstrual fluid composition and menstrual cycle characteristics will also be determined. Methods and analysis This is a case–control study of women who have experienced a late miscarriage, spontaneous preterm birth or preterm stillbirth or a pregnancy complicated by placental insufficiency (fetal growth restriction or pre-eclampsia), compared with those who have had a healthy term birth. Cases will be matched for maternal age, body mass index and gravidity. Participants will not currently be on hormonal therapy. Women will be provided with a menstrual cup and will collect their sample on day 2 of menstruation. Primary exposure measures include morphological and functional differences in decidualisation of the endometrium (cell types, immune cell subpopulations and protein composition secreted from the decidualised endometrium). Women will complete a menstrual history survey to capture menstrual cycle length, regularity, level of pain and heaviness of flow. Ethics and dissemination Ethics approval was obtained from Monash University Human Research Ethics Committee (27900) on 14/07/2021 and will be conducted in accordance with these conditions. Findings from this study will be disseminated through peer-reviewed publications and conference presentations.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Premature Birth Stillbirth Stillbirth Stillbirth Stillbirth Stillbirth Stillbirth Stillbirth

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pmc
last seen: 2026-05-17T02:30:03.883495+00:00
pubmed
last seen: 2026-05-25T00:33:42.232554+00:00
License: CC0 · commercial use OK